TL;DR
Get workout gear delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A new Veterans Affairs policy will require signed consent and documented risk-benefit discussions before younger veterans receive antidepressant prescriptions, according to a report cited by MedPage Today. Separately, a randomized trial found that an investigational smartphone app reduced negative symptoms of schizophrenia, and a small pilot trial linked reduced ultraprocessed food intake with lower depression and anxiety scores. The reports do not establish how broadly these findings apply or whether the app and diet approach will become routine care.
The Department of Veterans Affairs will require younger veterans to sign consent forms and have discussions about antidepressant risks and benefits documented before receiving a prescription, according to a New York Times report summarized by MedPage Today on September 30. The same roundup cited a randomized trial in which an investigational app reduced negative symptoms of schizophrenia and a small diet trial that found lower depression and anxiety scores when participants cut back on ultraprocessed foods.
The VA policy adds documentation steps for clinicians treating younger veterans with antidepressants. The summary does not specify the age range covered, when the policy takes effect, which medications or clinical situations are included, or how clinicians must conduct the risk-benefit discussion. It also does not describe the evidence or reasoning the VA cited for the change. Those details will shape how the policy affects veterans seeking treatment.
In a separate development, a randomized trial reported that an investigational smartphone app reduced the severity of negative symptoms in people with schizophrenia. MedPage Today cited the study as published in JAMA Network Open. The roundup did not identify the app, give the size or duration of the trial, quantify the change in symptoms, or report whether benefits extended to other symptoms or daily functioning.
A small pilot crossover trial, also cited in the roundup, found lower depression and anxiety scores among patients with major depressive disorder when they reduced ultraprocessed foods in their diets. The study appeared in JAMA Psychiatry, according to MedPage Today. The summary gives no participant count, duration, score changes, or details of the comparison diet. The finding is an early study result, not evidence that dietary changes can replace established depression treatment.
New Steps and Early Care Findings
The VA policy concerns access to antidepressant treatment for younger veterans: requiring signed consent and recorded discussions could change what happens before a prescription is issued. The reported information does not say whether prescriptions will be delayed or denied, or how the policy will affect patients already receiving medication. Those practical effects remain unknown.
The app and diet findings address possible additions to mental health care, but each has important limits. The app result comes from a trial, yet the available summary does not show the size or durability of the benefit. The diet result is from a small pilot study and reports changes in symptom scores, not proof that reducing ultraprocessed foods treats depression. Readers should not take either summary as a clinical recommendation.
Together, the items point to different questions facing mental health care: how to document medication decisions, whether digital tools can help with schizophrenia symptoms, and whether dietary changes merit further study in depression. The evidence described here is not detailed enough to resolve those questions or establish how the findings apply to individual patients.
Top picks for "antidepressant aids schizophrenia"
As an affiliate, we earn on qualifying purchases.
Three Developments in Psychiatry
MedPage Today presented the items as part of a psychiatry news roundup published September 30, 2026, rather than as one connected study or policy announcement. Its summary attributed the VA policy report to The New York Times and linked the schizophrenia app trial to JAMA Network Open. The diet study was reported in JAMA Psychiatry.
The three developments have different evidence and policy status. The VA item describes a policy requirement, while the app and diet items describe research findings. A randomized trial can test an intervention under defined study conditions; a small pilot trial can help guide further research. Neither description alone establishes routine effectiveness across different patients and care settings.
“Younger veterans will need signed consent forms and documented discussions about antidepressant risks and benefits before receiving a prescription.”
— MedPage Today, summarizing a New York Times report
Policy Scope and Study Limits
The VA policy summary leaves several practical details unanswered, including the age cutoff, start date, exceptions, and whether the requirement applies to all antidepressant prescriptions. The underlying policy language and the VA’s stated rationale are not included in the source material provided here.
For the app trial, the available account does not identify the app or report the number of participants, the size and duration of the effect, or possible adverse effects. It is also unclear whether symptoms improved after the trial ended. For the diet study, the summary does not give the sample size, length of the intervention, amount of food reduction, or comparison conditions. It does not establish whether lower scores lasted or resulted from the dietary change itself.
Details Needed for Follow-Up
Further reporting on the VA policy would need to establish when it starts, which younger veterans it covers, and what clinicians must document. The trial papers can clarify the app’s design, participant numbers, measured outcomes, and whether researchers plan additional testing. More information on the diet trial’s methods and results will be needed to judge what research should follow. Until those details are available, the policy’s reach and the studies’ implications for routine care remain unsettled.
Key Questions
What will the VA require before prescribing antidepressants to younger veterans?
According to a New York Times report summarized by MedPage Today, clinicians will need a signed consent form and documentation of a discussion about antidepressant risks and benefits. The reported summary does not specify the age range or effective date.
Did the schizophrenia app cure or treat all symptoms?
No such conclusion is supported by the summary. It says a randomized trial found reduced severity of negative symptoms. It does not report effects on other symptoms, cure, long-term benefit, or everyday functioning.
Does the diet study show that changing food choices treats depression?
No. The small pilot crossover trial reported lower depression and anxiety scores when participants with major depressive disorder reduced ultraprocessed foods. The reported finding does not establish that the change caused the improvement or that it can replace established care.
When will the app or diet approach be available as standard care?
The source summary gives no timeline for either. It does not say whether the app will be tested further or whether additional diet studies are planned.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
